Literature DB >> 18406382

The innate immune response against Leishmania parasites.

Jan Liese1, Ulrike Schleicher, Christian Bogdan.   

Abstract

Parasites of the genus Leishmania are the causative agents of cutaneous, mucocutaneous or visceral leishmaniasis. The parasite species and host genetic factors determine the quality of the immune response and thereby the outcome of the infection. Here, we summarize previously published and present novel data on several aspects of the early innate immune reaction to Leishmania (L.) major, L. braziliensis and L. infantum, which cause cutaneous, mucocutaneous or visceral leishmaniasis, respectively. We will focus on (1) the effector molecules that contribute to the control of the parasite in the skin, lymph nodes and/or spleen; and (2) on the pattern recognition receptors (Toll-like receptors, TLRs), cell types (myeloid dendritic cells, plasmacytoid dendritic cells), cytokines (IL-12, IFN-alpha/beta), and signaling pathways (Tyk2 kinase) that are necessary for the initial sensing of the parasites and the subsequent development of an efficient NK cell response.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18406382     DOI: 10.1016/j.imbio.2007.12.005

Source DB:  PubMed          Journal:  Immunobiology        ISSN: 0171-2985            Impact factor:   3.144


  60 in total

1.  Toll-like receptors participate in macrophage activation and intracellular control of Leishmania (Viannia) panamensis.

Authors:  Carolina Gallego; Douglas Golenbock; Maria Adelaida Gomez; Nancy Gore Saravia
Journal:  Infect Immun       Date:  2011-04-25       Impact factor: 3.441

2.  Leishmania major attenuates host immunity by stimulating local indoleamine 2,3-dioxygenase expression.

Authors:  Levi H C Makala; Babak Baban; Henrique Lemos; Ahmed R El-Awady; Phillip R Chandler; De-Yan Hou; David H Munn; Andrew L Mellor
Journal:  J Infect Dis       Date:  2011-01-31       Impact factor: 5.226

Review 3.  The role of the anaphylatoxins in health and disease.

Authors:  Andreas Klos; Andrea J Tenner; Kay-Ole Johswich; Rahasson R Ager; Edimara S Reis; Jörg Köhl
Journal:  Mol Immunol       Date:  2009-05-28       Impact factor: 4.407

4.  Indoleamine 2,3-dioxygenase (IDO) induced by Leishmania infection of human dendritic cells.

Authors:  M J Donovan; V Tripathi; M A Favila; N S Geraci; M C Lange; W Ballhorn; M A McDowell
Journal:  Parasite Immunol       Date:  2012-10       Impact factor: 2.280

5.  Solute carrier protein family 11 member 1 (Slc11a1) activation efficiently inhibits Leishmania donovani survival in host macrophages.

Authors:  Nisha Singh; Mallikarjuna Rao Gedda; Neeraj Tiwari; Suya P Singh; Surabhi Bajpai; Rakesh K Singh
Journal:  J Parasit Dis       Date:  2016-11-12

Review 6.  Identifying vaccine targets for anti-leishmanial vaccine development.

Authors:  Shyam Sundar; Bhawana Singh
Journal:  Expert Rev Vaccines       Date:  2014-04       Impact factor: 5.217

7.  IL-18, but not IL-15, contributes to the IL-12-dependent induction of NK-cell effector functions by Leishmania infantum in vivo.

Authors:  Simone Haeberlein; Heidi Sebald; Christian Bogdan; Ulrike Schleicher
Journal:  Eur J Immunol       Date:  2010-06       Impact factor: 5.532

8.  The SPRY domain-containing SOCS box protein SPSB2 targets iNOS for proteasomal degradation.

Authors:  Zhihe Kuang; Rowena S Lewis; Joan M Curtis; Yifan Zhan; Bernadette M Saunders; Jeffrey J Babon; Tatiana B Kolesnik; Andrew Low; Seth L Masters; Tracy A Willson; Lukasz Kedzierski; Shenggen Yao; Emanuela Handman; Raymond S Norton; Sandra E Nicholson
Journal:  J Cell Biol       Date:  2010-07-05       Impact factor: 10.539

9.  LXR deficiency confers increased protection against visceral Leishmania infection in mice.

Authors:  Kevin W Bruhn; Chaitra Marathe; Ana Cláudia Maretti-Mira; Hong Nguyen; Jacquelyn Haskell; Thu Anh Tran; Veena Vanchinathan; Upasna Gaur; Mary E Wilson; Peter Tontonoz; Noah Craft
Journal:  PLoS Negl Trop Dis       Date:  2010-11-16

10.  Human immunodeficiency virus and leishmaniasis.

Authors:  Navid Ezra; Maria Teresa Ochoa; Noah Craft
Journal:  J Glob Infect Dis       Date:  2010-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.